RG 7835
Alternative Names: IgG-IL2 FP; RG-7835; RO 7049665Latest Information Update: 05 Nov 2023
At a glance
- Originator Roche
- Class Anti-inflammatories; Hepatoprotectants; Recombinant fusion proteins
- Mechanism of Action Regulatory T-lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Autoimmune hepatitis
- No development reported Autoimmune disorders; Ulcerative colitis
Most Recent Events
- 28 Mar 2023 No recent reports of development identified for phase-I development in Autoimmune-disorders(In volunteers) in Netherlands (SC, Injection)
- 28 Mar 2023 No recent reports of development identified for phase-I development in Ulcerative-colitis(In the elderly, In adults) in Georgia (SC)
- 28 Mar 2023 No recent reports of development identified for phase-I development in Ulcerative-colitis(In the elderly, In adults) in Moldova (SC)